Research Paper Volume 12, Issue 14 pp 14271—14284

Analysis of the expression and genetic alteration of CLDN18 in gastric cancer

Figure 4. Expression changes of CLDN18 in precancerous tissues of the stomach. (A) The difference in CLDN18 expression between intestinal metaplasia (IM) and healthy controls. (B) The difference in CLDN18 expression among chronic gastritis (CG), low grade intraepithelial neoplasia (LGIN), high grade intraepithelial neoplasia (HGIN), and early gastric cancer (EGC). FC, fold change.